 Connection
Cari Berget to Male
This is a "connection" page, showing publications Cari Berget has written about Male.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.231 |
|
|
|
-
Berget C, Cobry E, Escobar E, Towers L, Sakomoto C, Taylor K, Trojanowski PJ, Wadwa RP, Forlenza GP. Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12?months. Diabetes Obes Metab. 2025 Sep; 27(9):4942-4949.
Score: 0.033
-
Berget C, Annan SF, Biester T, Choudhary P, Forlenza GP, Peters AL, Renard E, Deiss D. Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe. Diabetes Obes Metab. 2025 Jun; 27(6):2909-2919.
Score: 0.033
-
Marks BE, Meighan S, Fivekiller EE, Escobar E, Berget C. Ketone Management in Pediatric Diabetes Centers in the USA: Current Practices and a Call for Improved Standardization. Horm Res Paediatr. 2026; 99(1):113-121.
Score: 0.032
-
Berget C, Messer LH, Vigers T, Frohnert BI, Pyle L, Wadwa RP, Driscoll KA, Forlenza GP. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatr Diabetes. 2020 03; 21(2):310-318.
Score: 0.023
-
Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, Alonso GT. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic. J Diabetes Sci Technol. 2020 03; 14(2):290-296.
Score: 0.021
-
Moscoso-Vasquez M, Ekhlaspour L, Brown SA, DeBoer MD, Berget C, Cobry EC, Wadwa RP, Capodanno G, Cengiz E, Wong JC, Pryor EC, Villa-Tamayo MF, El Fathi A, Holmes V, Davis Prince S, Escobar E, Towers L, Hosseininpour Y, Narayan A, Koravi CLK, Nguyen T, Fulkerson D, Barnett CL, Oliveri MC, Breton MD, Forlenza GP. Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes. Diabetes Care. 2026 Mar 01; 49(3):401-409.
Score: 0.009
-
Berg AK, Passanisi S, von dem Berge T, Chobot A, Elbarbary NS, Pelicand J, Giraudo FS, Mentink R, Levy-Khademi F, Creo AL, Heidemann MS, Piona C, Arslan E, Gunes Kaya D, Sas TCJ, Krogvold L, Tumini S, Berget C, Dos Santos TJ, Karges B, Zorron M, Svensson J. SKIN-PEDIC: A Worldwide Assessment of Skin Problems in Children and Adolescents Using Diabetes Devices. Horm Res Paediatr. 2026; 99(5):666-679.
Score: 0.008
-
Waterman LA, Pyle L, Forlenza GP, Towers L, Karami AJ, Jost E, Berget C, Wadwa RP, Cobry EC. Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions. Diabetes Technol Ther. 2024 09; 26(9):626-632.
Score: 0.008
-
Forlenza GP, DeSalvo DJ, Aleppo G, Wilmot EG, Berget C, Huyett LM, Hadjiyianni I, Méndez JJ, Conroy LR, Ly TT, Sherr JL. Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technol Ther. 2024 08; 26(8):514-525.
Score: 0.008
-
Cobry EC, Pyle L, Waterman LA, Forlenza GP, Towers L, Karami AJ, Jost E, Berget C, Wadwa RP. Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions. Diabetes Technol Ther. 2024 02; 26(2):119-124.
Score: 0.008
-
Messer LH, Berget C, Pyle L, Vigers T, Cobry E, Driscoll KA, Forlenza GP. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2021 12; 23(12):837-843.
Score: 0.006
-
Majidi S, Reid MW, Fogel J, Anderson B, Klingensmith GJ, Cain C, Berget C, Raymond JK. Psychosocial outcomes in young adolescents with type 1 diabetes participating in shared medical appointments. Pediatr Diabetes. 2021 08; 22(5):787-795.
Score: 0.006
-
Messer LH, Berget C, Ernst A, Towers L, Slover RH, Forlenza GP. Initiating hybrid closed loop: A program evaluation of an educator-led Control-IQ follow-up at a large pediatric clinic. Pediatr Diabetes. 2021 06; 22(4):586-593.
Score: 0.006
-
Messer LH, Berget C, Vigers T, Pyle L, Geno C, Wadwa RP, Driscoll KA, Forlenza GP. Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes. 2020 03; 21(2):319-327.
Score: 0.006
-
Sherr JL, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu L, Berget C, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, Ly TT. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technol Ther. 2020 03; 22(3):174-184.
Score: 0.006
-
Bakhach M, Reid MW, Pyatak EA, Berget C, Cain C, Thomas JF, Klingensmith GJ, Raymond JK. Home Telemedicine (CoYoT1 Clinic): A Novel Approach to Improve Psychosocial Outcomes in Young Adults With Diabetes. Diabetes Educ. 2019 08; 45(4):420-430.
Score: 0.005
-
O'Donnell HK, Berget C, Wooldridge JS, Driscoll KA. Graduated exposure to treat fear of hypoglycemia in a young adult with type 1 diabetes: A case study. Pediatr Diabetes. 2019 02; 20(1):113-118.
Score: 0.005
-
Reid MW, Krishnan S, Berget C, Cain C, Thomas JF, Klingensmith GJ, Raymond JK. CoYoT1 Clinic: Home Telemedicine Increases Young Adult Engagement in Diabetes Care. Diabetes Technol Ther. 2018 05; 20(5):370-379.
Score: 0.005
-
Raymond JK, Berget CL, Driscoll KA, Ketchum K, Cain C, Fred Thomas JF. CoYoT1 Clinic: Innovative Telemedicine Care Model for Young Adults with Type 1 Diabetes. Diabetes Technol Ther. 2016 06; 18(6):385-90.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|